Literature DB >> 23708701

Avoidance of exenteration in orbital sebaceous gland carcinoma with neoadjuvant chemotherapy.

Ajay Gogia1, Neelam Pushker, Seema Sen, Sameer Bakhshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23708701     DOI： 10.1007/s00417-013-2382-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

1.  Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.

Authors:  H C Russell; V Chadha; D Lockington; E G Kemp
Journal:  Br J Ophthalmol       Date:  2010-06-08       Impact factor: 4.638

2.  Neoadjuvant chemotherapy in recurrent sebaceous carcinoma of eyelid with orbital invasion and regional lymphadenopathy.

Authors:  Omega Priyadarshini; Ghanashyam Biswas; Sutapa Biswas; Rajesh Padhi; Suryasnata Rath
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 Sep-Oct       Impact factor: 1.746

3.  Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Authors:  K Winkler; G Beron; G Delling; U Heise; H Kabisch; C Purfürst; J Berger; J Ritter; H Jürgens; V Gerein
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

4.  Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis.

Authors:  Ramesh Murthy; Santosh G Honavar; Sanghamitra Burman; Geeta K Vemuganti; Milind N Naik; Vijay Anand P Reddy
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2005-07       Impact factor: 1.746

5.  Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.

Authors:  Amina Husain; George Blumenschein; Bita Esmaeli
Journal:  Int J Dermatol       Date:  2008-03       Impact factor: 2.736

Review 6.  Combined therapeutic approach for extraorbital sebaceous carcinoma in a Torre's syndrome.

Authors:  B el Nakadi; C Nouwynck; A Salhadin
Journal:  Eur J Surg Oncol       Date:  1995-06       Impact factor: 4.424
  6 in total
  4 in total

Review 1.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

2.  Neoadjuvant Systemic Chemotherapy in Sebaceous Gland Carcinoma of the Eyelid: A Retrospective Study.

Authors:  Saurav Verma; Nipun Kumar; Rachna Meel; Seema Sen; Seema Kashyap; Sanjay Sharma; Neelam Pushker; Deepam Pushpam; Sameer Bakhshi
Journal:  Ocul Oncol Pathol       Date:  2021-05-05

3.  Neoadjuvant chemotherapy for invasive squamous cell carcinoma of the conjunctiva: A case report.

Authors:  Akshay Gopinathan Nair; Swathi Kaliki; Dilip Kumar Mishra; Vijay Anand Reddy; Milind N Naik
Journal:  Indian J Ophthalmol       Date:  2015-12       Impact factor: 1.848

Review 4.  Updates on the clinical diagnosis and management of ocular sebaceous carcinoma: a brief review of the literature.

Authors:  Yangfan Xu; Fang Li; Renbing Jia; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2018-06-27       Impact factor: 4.147
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.